Rheumatoid Arthritis Treatment Seen as Substandard for Most Patients
(MedPage Today) -- Clinicians could improve outcomes in their patients with rheumatoid arthritis (RA) by paying attention to certain markers of care quality, such as early referral to certified rheumatologists and prescribing standard drugs for... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 12, 2022 Category: Rheumatology Source Type: news
Not Just a Miner's Problem: Workplace Fumes, Dust Tied to RA
(MedPage Today) -- Adding to previous studies implicating on-the-job exposure to silica dust as a risk factor for rheumatoid arthritis (RA), new research now finds dozens of other occupational inhalants that also appear to contribute to RA development... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 6, 2022 Category: Rheumatology Source Type: news
Cardiovascular Risk Marker Improved With Common Rheumatoid Arthritis Drugs
(MedPage Today) -- Rheumatoid arthritis patients treated with medications targeting the tumor necrosis factor (TNF) pathway or with standard disease-modifying anti-rheumatic drugs (DMARDs) showed substantial reductions in arterial inflammation... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 2, 2022 Category: Rheumatology Source Type: news
Common Treatments for Knee Osteoarthritis May Be Harmful
(MedPage Today) -- CHICAGO -- Common treatments for people living with osteoarthritis of the knee -- such as steroid injections or anti-inflammatory agents -- reduced pain, but were also associated with increasing damage to the joints, researchers... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 30, 2022 Category: Rheumatology Source Type: news
Lupus Linked With Greater Risk of Cardiovascular Complications of Childbirth
(MedPage Today) -- Pregnant women with systemic lupus erythematosus (SLE) were more prone to cardiovascular complications during delivery, and their risk seems to have increased over the past 15 years, according to national administrative data... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 29, 2022 Category: Rheumatology Source Type: news
Bone Drug Reverses Damage in Hand Osteoarthritis
(MedPage Today) -- PHILADELPHIA -- The osteoporosis drug denosumab (Prolia) not only stopped structural progression in patients with erosive osteoarthritis of the hand, but showed signs of reversing the damage, according to findings from a small... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 15, 2022 Category: Rheumatology Source Type: news
Two Surgery Types Yield Similar Results in Advanced Ankle Osteoarthritis
(MedPage Today) -- Patients with end-stage ankle osteoarthritis had similar outcomes from either total ankle replacement (TAR) or ankle fusion surgery, the randomized open-label TARVA trial showed.
At 52 weeks, improvements were similar between... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 15, 2022 Category: Rheumatology Source Type: news
Another Adalimumab Biosimilar Seems Set for Interchangeability
(MedPage Today) -- PHILADELPHIA -- Pfizer has made the case for gaining the coveted "interchangeability" status for its adalimumab biosimilar (Abrilada), a study presented here suggested.
A pivotal trial involving nearly 445 rheumatoid arthritis... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2022 Category: Rheumatology Source Type: news
Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis
(MedPage Today) -- PHILADELPHIA -- Aimed at treating rheumatoid arthritis, an investigational antibody drug that stimulates checkpoint activity yielded good results in a phase II study reported here.
After 12 weeks, patients assigned to the... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2022 Category: Rheumatology Source Type: news
Safer Alternative to Cyclophosphamide at Hand for ILD?
(MedPage Today) -- PHILADELPHIA -- Rituximab (Rituxan) matched IV cyclophosphamide for improving lung function in patients with interstitial lung disease (ILD) related to systemic sclerosis and other connective tissue diseases, and was associated... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2022 Category: Rheumatology Source Type: news
Novel BTK Inhibitor Looks Good for Sjogren's Syndrome
(MedPage Today) -- PHILADELPHIA -- Remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, appeared effective in reducing signs of Sjogren's syndrome in a randomized, placebo-controlled trial.
Scores on the EULAR Sjogren's... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2022 Category: Rheumatology Source Type: news
Sjogren's Responds to Cytokine Treatment, Early Data Show
(MedPage Today) -- Most patients with Sjogren's syndrome treated with low doses of interleukin-2 (IL-2) in a randomized, placebo-controlled trial showed significant improvement, researchers said.
After 24 weeks in the 60-person trial, 66.7% of... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 11, 2022 Category: Rheumatology Source Type: news
New ACR/EULAR Guideline Expands RA Remission Definition
(MedPage Today) -- Newly released guidance for defining remission in rheumatoid arthritis (RA) is expected to increase the number of patients achieving it while maintaining its ability to predict good objective outcomes.
The more relaxed criteria... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - October 25, 2022 Category: Rheumatology Source Type: news
Study: Patient Reports Can Substitute for Objective Measures in RA Evaluation
(MedPage Today) -- A model incorporating rheumatoid arthritis (RA) patients' self-reports matched conventional physician-led evaluations of disease activity to an acceptable degree, researchers said.
"Machine learning" applied to data collected... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - October 13, 2022 Category: Rheumatology Source Type: news
What Caused Left-Sided Hearing Loss in This 65-Year-Old Man?
(MedPage Today) -- Numerous diagnostic procedures revealed tophaceous gout affecting the middle ear (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - October 3, 2022 Category: Rheumatology Source Type: news
